CRB-913
CANYON-1
Corbus Pharmaceuticals · Phase 1 · Completed · Enrollment 254
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
CRB-913
Corbus Pharmaceuticals · Phase 1 · Completed · Enrollment 254
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.